<!DOCTYPE HTML>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en-us">

  <head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="description" content="abregen">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta http-equiv="X-UA-Compatible" content="IE=9" />

  <title>
    
      Therapeutic Focus &middot; AbRegen
    
  </title>

  <!-- CSS -->
  <link rel="stylesheet" href="/abregen/public/css/bootstrap.min.css">
  <link rel="stylesheet" href="/abregen/public/css/font-awesome.min.css">
  <link rel="stylesheet" href="/abregen/public/css/global.css">

  <!-- Icons -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="/abregen/public/apple-touch-icon-144-precomposed.png">
  <link rel="shortcut icon" href="/abregen/public/images/favicon.ico">

  <!-- Javascript -->
  <script type="text/javascript" src="/abregen/public/js/jquery.js"></script>
  <script type="text/javascript" src="/abregen/public/js/bootstrap.min.js"></script>
  
  
  

  <!-- RSS -->
  <link rel="alternate" type="application/rss+xml" title="RSS" href="/abregen/atom.xml">
</head>


  <body>

    <div class="navbar navbar-default" role="navigation">
      <div class="container-fluid">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="sr-only">Toggle navigation</span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/abregen/"><img src="/abregen/public/images/logo.png" /></a>
        </div>
        <div class="navbar-collapse collapse">
            <ul class="nav navbar-nav">
              
                
                  
                
                
                    <li class=""><a href="/abregen/">Home</a></li>
                
              
                
                  
                
                
                    <li class=""><a href="/abregen/board_and_management">Board and Management</a></li>
                
              
                
                  
                
                
                  <li class="dropdown ">
                    <a href="" class="dropdown-toggle" data-toggle="dropdown">Technology<b class="caret"></b></a>
                    <ul class="dropdown-menu">
                      
                        <li><a href="/abregen/flightless_1">Flightless 1</a></li>
                      
                        <li><a href="/abregen/publications">Publications</a></li>
                      
                    </ul>
                  </li>
                
              
                 
                  
                
                
                    <li class="active"><a href="/abregen/therapeutic_focus">Therapeutic Focus</a></li>
                
              
                
                  
                
                
                    <li class=""><a href="/abregen/news">News</a></li>
                
              
                
                  
                
                
                    <li class=""><a href="/abregen/contact">Contact</a></li>
                
              
            </ul>
        </div><!--/.nav-collapse -->
      </div>
    </div>


    
    <div class="container cp-content">
  <div class="cp-page-title">Therapeutic Focus</div>
  <p class="lead">
	Inherited epidermolysis bullosa (EB) is a group of genetic disorders characterised by fragility of the skin. Recurrent blister formation results from even minor trauma to the skin, which in turn can cause chronic wounds, infection and scarring. Depending on the EB subtype, patients can experience ongoing pain, disability, corneal lesions, oesophageal strictures, compromised nutrition, failure to thrive, growth retardation and debilitating hand and foot deformities. Patients with recessive dystrophic epidermolysis bullosa (RDEB) are also at high risk of developing skin-derived squamous cell carcinomas that are particularly aggressive and invasive, and are a major cause of death in this patient population. There are currently no available treatments for EB that target the mechanisms of skin fragility and blister formation.
</p>

<div class="row">
	<div class="col-sm-4">
		<p class="lead">
			Inherited EB is caused by mutations to structural proteins in the skin.  Patients with dystrophic EB have mutations within the gene for type VII collagen, resulting in deficient or absent anchoring fibrils.  Separation of the epidermis from the dermis can occur with even minor trauma, resulting in blister formation.
		</p>
	</div>
	<div class="col-sm-7 col-xs-4-offset-1">
		<img class="img-thumbnail img-responsive" src="/abregen/public/images/epidermal_bullosa.png"/>
	</div>
</div>
<!-- http://www.shutterstock.com/pic-105160253/stock-vector-drawing-of-blister-formation-in-skin-disease-such-as-epidermolysis-bullosa-where-the-epidermis.html?src=fosCeHX8VvAOyOPOxDkV6g-1-0 -->

</br>
<h5>For further information on EB: </h5>

<h5 class="cp-pub">
	Kopecki Z, Murrell DF & Cowin AJ  Raising the roof on epidermolysis bullosa (EB): a focus on new therapies Wound Practice and Research 17(2)  (<a target="_blank" href="http://www.awma.com.au/journal/1702.php">http://www.awma.com.au/journal/1702.php</a>)
</h5>
<br>
<div class="row">
	<div class="col-sm-3 col-xs-6">
		<div class="thumbnail">
			<a target="_blank" href="http://www.debra.org.au/"><img  src="/abregen/public/images/debra_aus.png" /></a>
		</div>
	</div>
	<div class="col-sm-3 col-xs-6">
		<div class="thumbnail">
			<a target="_blank" href="http://www.debra-international.org/homepage.html"><img  src="/abregen/public/images/debra_int.png" /></a>
		</div>
	</div>
</div>
</div>

   

     <!-- <div class="navbar navbar-default" role="navigation" style="padding-top:10px; margin-bottom:0;">
      <div class="container">
        <address>
          <strong>Twitter, Inc.</strong><br>
          795 Folsom Ave, Suite 600<br>
          San Francisco, CA 94107<br>
          <abbr title="Phone">P:</abbr> (123) 456-7890
        </address>

        <address>
          <strong>Full Name</strong><br>
          <a href="mailto:#">first.last@example.com</a>
        </address>
      </div>
    </div>
 -->
  <div class="container-fluid cp-footer">    
    <div class="row">
      <div class="col-sm-12">
          
            
              
            
            
               <div class="badge ">
                <a href="/abregen/">Home</a>
              </div>
              
            
            
              
            
            
               <div class="badge ">
                <a href="/abregen/board_and_management">Board and Management</a>
              </div>
              
            
            
              
            
            
              
              <div class="badge ">
                <a href="/abregen/flightless_1">Flightless 1</a>
              </div>
              
              <div class="badge ">
                <a href="/abregen/publications">Publications</a>
              </div>
              
            
            
             
              
            
            
               <div class="badge active">
                <a href="/abregen/therapeutic_focus">Therapeutic Focus</a>
              </div>
              
            
            
              
            
            
               <div class="badge ">
                <a href="/abregen/news">News</a>
              </div>
              
            
            
              
            
            
               <div class="badge ">
                <a href="/abregen/contact">Contact</a>
              </div>
              
            
      </div>
    </div>
  </div>
  <div class="cp-copyright"> &copy; 2014 AbRegen Pty Ltd</div>

    


  </body>
</html>
